Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-25T13:41:45.858Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes in 5-Hydroxytryptophan Metabolism in Depression

Published online by Cambridge University Press:  29 January 2018

Alec Coppen ,
David Murray Shaw  and
Andrew Malleson
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
The British Journal of Psychiatry , Volume 111 , Issue 470 , January 1965 , pp. 105 - 107
Copyright
Copyright © Royal College of Psychiatrists, 1965 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Coppen, A., Shaw, D. M., and Farrell, J. P. (1963). Potentiation of the antidepressive effect of a monoamineoxidase inhibitor by tryptophan. Lancet, i, 79–81.CrossRefGoogle Scholar
Mezey, A. G., and Coppen, A. J. (1961). Respiratory adaptation to exercise in anxious patients. Cli. Sci., 20, 171–175.Google Scholar
Hansson, E., and Clark, W. G. (1962). Studies on dopa decarboxylase in vivo by use of 14C-carboxyl labelled dopa. Proc. Soc. exp. Biol., 111, 793–798.Google Scholar
Hansson, E., Fleming, R. M., and Clark, W. G. (1964). Effect of some benzyl hydrazines and benzyloxyamines on dopa and 5-hydroxytryptophan decarboxylase in vivo. Int. J. Neuropharmacol., 3, 177–188.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.